WIN-Partners Co., Ltd. (TYO:3183)
1,188.00
-13.00 (-1.08%)
Jun 4, 2026, 3:30 PM JST
WIN-Partners Revenue
In the fiscal year ending March 31, 2026, WIN-Partners had annual revenue of 90.39B JPY with 11.03% growth. WIN-Partners had revenue of 24.11B in the quarter ending March 31, 2026, with 14.99% growth.
Revenue
90.39B
Revenue Growth
+11.03%
P/S Ratio
0.36
Revenue / Employee
143.48M
Employees
630
Market Cap
32.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 90.39B | 8.98B | 11.03% |
| Mar 31, 2025 | 81.41B | 4.35B | 5.64% |
| Mar 31, 2024 | 77.06B | 6.21B | 8.76% |
| Mar 31, 2023 | 70.85B | 4.46B | 6.72% |
| Mar 31, 2022 | 66.39B | 4.27B | 6.87% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.51T |
| Otsuka Holdings | 2.52T |
| Chugai Pharmaceutical | 1.29T |
| HOYA Corporation | 947.75B |
| YAKUODO HOLDINGS | 163.81B |
| Amvis Holdings | 50.95B |
| Daito Pharmaceutical | 50.77B |
| MTI Ltd. | 30.69B |